Biolog

Biolog, Inc. is a privately held company that began operations in Hayward California in 1984, where the company remains headquartered today. The company’s product lines have been built upon patented technology that greatly simplifies cell identification and characterization, with applicability across basic research, bioprocess, sustainable agriculture and other markets where microorganism characterization is key to success.

In 2022, Biolog received funding from private investors including BroadOak Capital and Research Corporation Technologies. That spurred additional growth, including the acquisition of MIDI Labs, now Biolog Lab Services,  a business that founded the DNA sequencing method for microbial identification and has, for over two decades, delivered critical, time-sensitive ID for pharmaceutical, probiotic, food and beverage, and personal care manufacturing customers.  

Today, Biolog produces instrumentation, test panels, and critical software for phenotype characterization in microbial organisms, mammalian cell lines, and community analysis. We also produce microbial identification panels to enable the identification of bacteria, yeast, and fungi using our instruments. At our Newark, DE site we provide complementary laboratory services where, in addition to our phenotypic characterization tools we offer a full polyphasic approach for microbial ID, including genotypic and proteotypic services.

Biolog sells direct in the US, Germany, and Austria and through distribution channels throughout the rest of the world.